Subscribe Register Login
Thursday, April 26, 2018, 11:45 a.m.

This exclusive story is reserved for our subscribers.

Support independent journalism by subscribing to the Arkansas Democrat-Gazette.

Subscribe now to continue reading.

AstraZeneca rejects new Pfizer offer

LONDON -- The board of AstraZeneca on Monday rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, a decision that caused a sharp slide in the U.K. company's share price as many investors think it effectively brings an end to the protracted takeover attempt.

Click here to login or subscribe below.

BEST DEAL
7-Day
Home Delivery
& Online
Online Only
Get Started Get Started
Breaking News
Commenting
Newspaper Content Online
Smartphone Access
Tablet App (iPad) Access
Home Delivery
Sunday Comics, Ad Inserts, Coupons